Efficacy and Safety of Intravenous Chimeric Antigen Receptor T-Cell Therapy in Adults with Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Srisurapanont, Karan [1 ]
Nangsue, Chatchaya [1 ]
Tantiworawit, Adisak [2 ]
机构：
[1] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand
[2] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Hematol, Chiang Mai, Thailand
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-162411
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
627
引用
收藏
页码：9557 / 9558
页数：2
相关论文
共 50 条
  • [41] Chimeric antigen receptor T-cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis
    Shargian, Liat
    Raanani, Pia
    Yeshurun, Moshe
    Gafter-Gvili, Anat
    Gurion, Ronit
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (05) : 838 - 846
  • [42] Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
    Yamshon, Samuel
    Gribbin, Caitlin
    Chen, Zhengming
    Demetres, Michelle
    Pasciolla, Michelle
    Alhomoud, Mohammad
    Martin, Peter
    Shore, Tsiporah
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 73.e1 - 73.e12
  • [43] HIV prevalence in primary central nervous system lymphoma: A systematic review and meta-analysis
    Franca, Raduan Ahmed
    Travaglino, Antonio
    Varricchio, Silvia
    Russo, Daniela
    Picardi, Marco
    Pane, Fabrizio
    Pace, Mirella
    De Caro, Marialaura Del Basso
    Mascolo, Massimo
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [44] Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis
    Schmitt, Andreas M.
    Herbrand, Amanda K.
    Fox, Christopher P.
    Bakunina, Katerina
    Bromberg, Jacoline E. C.
    Cwynarski, Kate
    Doorduijn, Jeanette K.
    Ferreri, Andres J. M.
    Illerhaus, Gerald
    Issa, Samar
    Schorb, Elisabeth
    Zucca, Emanuele
    Hemkens, Lars G.
    Schandelmaier, Stefan
    Kasenda, Benjamin
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 548 - 557
  • [45] Axicabtagene Ciloleucel Chimeric Antigen Receptor T Cell Therapy in Lymphoma With Secondary Central Nervous System Involvement
    Novo, Mattia
    Ruff, Michael W.
    Skrabek, Pamela J.
    Lin, Yi
    MAYO CLINIC PROCEEDINGS, 2019, 94 (11) : 2361 - 2364
  • [46] Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
    Komal Adeel
    Nathan J. Fergusson
    Risa Shorr
    Harold Atkins
    Kevin A. Hay
    Systematic Reviews, 10
  • [47] Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis
    Adeel, Komal
    Fergusson, Nathan J.
    Shorr, Risa
    Atkins, Harold
    Hay, Kevin A.
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [48] Efficacy and Safety of Chimeric Antigen Receptor T Cell Therapy in Chronic Lymphocytic Leukemia: A Systematic Review
    Habib, Rooma
    Aiman, Wajeeha
    Garg, Ishan
    Niaz, Rabiya
    Butt, Sigmone Khalid
    Saeed, Memoona
    Zubair, Hina
    Kashif, Tooba
    Khan, Huda
    Farrukh, Mahwish
    Naveed, Madiha
    Tahir, Nayha
    Fatima, Aqsa
    Ali, Muhammad Ashar
    BLOOD, 2021, 138
  • [49] Systematic review and meta-analysis of the association between bridging therapy and outcomes of chimeric antigen receptor T cell therapy in patients with large B cell lymphoma
    Sun, Zhen
    Liu, MengSi
    CYTOTHERAPY, 2022, 24 (09) : 940 - 953
  • [50] Cognition following chimeric antigen receptor T-cell therapy: A systematic review
    Kazzi, Christina
    Kuznetsova, Valeriya
    Siriratnam, Pakeeran
    Griffith, Sarah
    Wong, Shu
    Tam, Constantine S.
    Alpitsis, Rubina
    Spencer, Andrew
    O'Brien, Terence J.
    Malpas, Charles B.
    Monif, Mastura
    JOURNAL OF AUTOIMMUNITY, 2023, 140
12345